Research Reports
January 28, 2021
Existing drug offers targeted treatment for aggressive breast cancer
A new study claims palbociclib, an approved breast cancer drug, can treat an aggressive form of the cancer, bringing hope to thousands of afflicted women in the UK.
![Existing drug offers targeted treatment for aggressive breast cancer](https://pharmaceutical-business-review.com/wp-content/uploads/2021/01/Institute-of-Cancer-Research-300x200.jpg)